Eisler Capital (Us) LLC Exelixis, Inc. Transaction History
Eisler Capital (Us) LLC
- $5.6 Trillion
- Q2 2024
A detailed history of Eisler Capital (Us) LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Eisler Capital (Us) LLC holds 36,563 shares of EXEL stock, worth $1.32 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,563
Previous 30,015
21.82%
Holding current value
$1.32 Million
Previous $712 Million
15.35%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
468Shares Held
240MCall Options Held
1.87MPut Options Held
1.12M-
Black Rock Inc. New York, NY33.5MShares$1.21 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$1.07 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$981 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$549 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$456 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.6B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...